BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 29904126)

  • 1. Effect of testosterone treatment on bone remodelling markers and mineral density in obese dieting men in a randomized clinical trial.
    Ng Tang Fui M; Hoermann R; Nolan B; Clarke M; Zajac JD; Grossmann M
    Sci Rep; 2018 Jun; 8(1):9099. PubMed ID: 29904126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of testosterone treatment on body fat and lean mass in obese men on a hypocaloric diet: a randomised controlled trial.
    Ng Tang Fui M; Prendergast LA; Dupuis P; Raval M; Strauss BJ; Zajac JD; Grossmann M
    BMC Med; 2016 Oct; 14(1):153. PubMed ID: 27716209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic response to testosterone treatment in dieting obese men with low testosterone levels in a randomized, placebo-controlled clinical trial.
    Ng Tang Fui M; Hoermann R; Prendergast LA; Zajac JD; Grossmann M
    Int J Obes (Lond); 2017 Mar; 41(3):420-426. PubMed ID: 28028318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Diet-Induced Weight Loss Lead to Bone Loss in Overweight or Obese Adults? A Systematic Review and Meta-Analysis of Clinical Trials.
    Zibellini J; Seimon RV; Lee CM; Gibson AA; Hsu MS; Shapses SA; Nguyen TV; Sainsbury A
    J Bone Miner Res; 2015 Dec; 30(12):2168-78. PubMed ID: 26012544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Romosozumab increases bone mineral density in postmenopausal Japanese women with osteoporosis: A phase 2 study.
    Ishibashi H; Crittenden DB; Miyauchi A; Libanati C; Maddox J; Fan M; Chen L; Grauer A
    Bone; 2017 Oct; 103():209-215. PubMed ID: 28687496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36 months controlled study.
    Aversa A; Bruzziches R; Francomano D; Greco EA; Fornari R; Di Luigi L; Lenzi A; Migliaccio S
    Aging Male; 2012 Jun; 15(2):96-102. PubMed ID: 22439807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome.
    Fairfield WP; Finkelstein JS; Klibanski A; Grinspoon SK
    J Clin Endocrinol Metab; 2001 May; 86(5):2020-6. PubMed ID: 11344201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of testosterone on body composition in obese men are not sustained after cessation of testosterone treatment.
    Ng Tang Fui M; Hoermann R; Zajac JD; Grossmann M
    Clin Endocrinol (Oxf); 2017 Oct; 87(4):336-343. PubMed ID: 28561278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Testosterone Treatment on Volumetric Bone Density and Strength in Older Men With Low Testosterone: A Controlled Clinical Trial.
    Snyder PJ; Kopperdahl DL; Stephens-Shields AJ; Ellenberg SS; Cauley JA; Ensrud KE; Lewis CE; Barrett-Connor E; Schwartz AV; Lee DC; Bhasin S; Cunningham GR; Gill TM; Matsumoto AM; Swerdloff RS; Basaria S; Diem SJ; Wang C; Hou X; Cifelli D; Dougar D; Zeldow B; Bauer DC; Keaveny TM
    JAMA Intern Med; 2017 Apr; 177(4):471-479. PubMed ID: 28241231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis.
    Isidori AM; Giannetta E; Greco EA; Gianfrilli D; Bonifacio V; Isidori A; Lenzi A; Fabbri A
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):280-93. PubMed ID: 16117815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Testosterone Treatment on Adipokines and Gut Hormones in Obese Men on a Hypocaloric Diet.
    Ng Tang Fui M; Hoermann R; Grossmann M
    J Endocr Soc; 2017 Apr; 1(4):302-312. PubMed ID: 29264488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral density and bone turnover in relation to serum leptin, alpha-ketoglutarate and sex steroids in overweight and obese postmenopausal women.
    Filip R; Raszewski G
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):214-20. PubMed ID: 18547340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [PHASIC CHANGES OF BONE MASS, BONE TURNOVER MARKERS, AND ESTROGEN LEVELS AT DIFFERENT TIME POINTS AFTER GLUCOCORTICOID INTERVENTION AND THEIR CORRELATION IN RATS].
    Ren H; Shen G; Jiang X; Liang D; Tang J; Cui J; Lin S; Zhuang H; Yang Z; Zhang S; Yao Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2015 Mar; 29(3):307-14. PubMed ID: 26455196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of testosterone therapy on bone turnover markers in obese males with type 2 diabetes and functional hypogonadism.
    Groti Antonič K
    Aging Male; 2022 Dec; 25(1):269-277. PubMed ID: 36355053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of mild Leydig cell dysfunction following cytotoxic chemotherapy on bone mineral density (BMD) and body composition.
    Howell SJ; Radford JA; Adams JE; Shalet SM
    Clin Endocrinol (Oxf); 2000 May; 52(5):609-16. PubMed ID: 10792341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Denosumab versus zoledronic acid in patients previously treated with zoledronic acid.
    Anastasilakis AD; Polyzos SA; Gkiomisi A; Saridakis ZG; Digkas D; Bisbinas I; Sakellariou GT; Papatheodorou A; Kokkoris P; Makras P
    Osteoporos Int; 2015 Oct; 26(10):2521-7. PubMed ID: 25990355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of testosterone therapy on lumbar spine and hip mineral density in elderly men.
    Basurto L; Zarate A; Gomez R; Vargas C; Saucedo R; Galván R
    Aging Male; 2008 Sep; 11(3):140-5. PubMed ID: 18821290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of oral testosterone undecanoate therapy on bone mineral density and body composition in 322 aging men with symptomatic testosterone deficiency: a 1-year, randomized, placebo-controlled, dose-ranging study.
    Bouloux PM; Legros JJ; Elbers JM; Geurts TB; Kaspers MJ; Meehan AG; Meuleman EJ;
    Aging Male; 2013 Jun; 16(2):38-47. PubMed ID: 23581697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels.
    Kenny AM; Prestwood KM; Gruman CA; Marcello KM; Raisz LG
    J Gerontol A Biol Sci Med Sci; 2001 May; 56(5):M266-72. PubMed ID: 11320105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of suppression of estrogen action by the p450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys.
    Wickman S; Kajantie E; Dunkel L
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3785-93. PubMed ID: 12915670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.